Cargando…

p-Aminosalicylic Acid (P.A.S.)

Detalles Bibliográficos
Autor principal:	Spring, F. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oliver and Boyd 1949
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301890/ https://www.ncbi.nlm.nih.gov/pubmed/18146307

Ejemplares similares

Para-Aminosalicylic Acid: Pas
Publicado: (1950)

Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains
por: Wei, Wenjing, et al.
Publicado: (2019)

Endometrial Tuberculosis Treated with Para-Aminosalicylic Acid (PAS): Report of a Case with Subsequent Pregnancy
por: Kullander, Stig
Publicado: (1952)

Self-Assembling Polymers with p-Aminosalicylate Anions Supported by Encapsulation of p-Aminosalicylate for the Improvement of Drug Content and Release Efficiency
por: Keihankhadiv, Shadi, et al.
Publicado: (2023)

P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy.
por: Lavigne, J. G., et al.
Publicado: (1977)

Para-Aminosalicylic Acid in Pulmonary Tuberculosis
por: Horne, Norman W.
Publicado: (1949)

Treatment of Tuberculous Empyæma with P.A.S.
por: Simpson, J.
Publicado: (1949)

Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
por: Abinusawa, Adeyinka, et al.
Publicado: (2015)

Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
por: Perrotta, Cristiana, et al.
Publicado: (2015)

Characterization of Graft Copolymers Synthesized from p-Aminosalicylate Functionalized Monomeric Choline Ionic Liquid
por: Mazur, Aleksy, et al.
Publicado: (2023)

Report on Cases Treated with P.A.S. at Robroyston Hospital, Glasgow
por: Summers, W. B.
Publicado: (1949)

Report of Cases Treated with P.A.S. at Robroyston Hospital, Glasgow
por: Bankier, J. D. H.
Publicado: (1949)

Clinical Study of the Use of Para-Aminosalicylic Acid in the Treatment of Pulmonary Tuberculosis
por: Donaldson, Rose I. L.
Publicado: (1949)

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
por: Broekman, Mark M. T. J., et al.
Publicado: (2015)

Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis
por: Pandey, Bharati, et al.
Publicado: (2019)

Synthesis and Characterization of Nano-Sized 4-Aminosalicylic Acid–Sulfamethazine Cocrystals
por: Salem, Ala’, et al.
Publicado: (2021)

Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps
por: Kirchner, Tina, et al.
Publicado: (2013)

The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats
por: Banaei, Shokofeh
Publicado: (2016)

Aminosalicylates and COVID-19: Facts or Coincidences?
por: Magro, Fernando, et al.
Publicado: (2021)

Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid
por: Shrivastava, P. K., et al.
Publicado: (2013)

The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
por: Rousseaux, Christel, et al.
Publicado: (2013)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

Hepatitis Occurring during P.A.S. Therapy: With Report of Two Cases
por: Cuthbert, Robert J.
Publicado: (1953)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019)

Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan
por: Shimodaira, Yosuke, et al.
Publicado: (2021)

A relative bioavailability study of 500 mg calcium p-aminosalicylate film coating tablet in healthy individuals
por: Cheng, Chinhwa, et al.
Publicado: (2013)

para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
por: Zheng, Jun, et al.
Publicado: (2013)

Synthesis and Characterization of Linear Copolymers Based on Pharmaceutically Functionalized Monomeric Choline Ionic Liquid for Delivery of p-Aminosalicylate
por: Keihankhadiv, Shadi, et al.
Publicado: (2023)

Effect of intra-abdominally administered mesalazine (5-aminosalicylic acid) in experimental peritonitis
por: Sener, Aziz, et al.
Publicado: (2018)

Test des moteurs pas à pas
por: Daneels, A, et al.
Publicado: (1976)

A Novel Preparation Method for 5-Aminosalicylic Acid Loaded Eudragit S100 Nanoparticles
por: Hu, Daode, et al.
Publicado: (2012)

A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis
por: Heo, Jinyeong, et al.
Publicado: (2022)

Comparative Study of the Treatment of Tuberculous Cervical Lymphadenitis with Special Reference of Streptomycin, P.A.S. and Isonicotinic Acid Hydrazide
por: Almast, Sansar Chand
Publicado: (1953)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019)

Sodium p-Aminosalicylic Acid Reverses Sub-Chronic Manganese-Induced Impairments of Spatial Learning and Memory Abilities in Rats, but Fails to Restore γ-Aminobutyric Acid Levels
por: Li, Shao-Jun, et al.
Publicado: (2017)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid
por: Fivian-Hughes, Amanda S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lmd4lkbfr7f2cim49vmu4e90pn